Follow on Google News News By Tag * Cord Blood Cells * Cord Blood Bank * Compare Cord Blood Banks * Baby Cord Blood Banking * Private Cord Blood Banking * Cord Bl * More Tags... Industry News News By Location Country(s) Industry News
Follow on Google News | Cryo-Cell International Shares Potentially Undervalued in Terms of Earnings YieldCompany Reported To Have Highest Earnings Yield in Health Care Services Industry
“The Company believes that our high earnings yield may assist investors in evaluating the relative potential value of Cryo-Cell as compared to other companies in the health care services industry," said Mercedes A. Walton, Chairman and CEO of Cryo-Cell International. "We anticipate that the Company’s global leadership in the health care services industry and within the stem cell sector in particular, may positively impact Cryo-Cell’s continuing progress towards building shareholder value." According to their analysis published on May 24, 2011, SmarTrend currently has shares of Cryo-Cell International in an Uptrend and issued the Uptrend alert on September 13, 2010 at $1.23. The stock has risen 169.4% since the Uptrend alert was issued. Cryo-Cell International stock closed at $3.35 per share on May 24, 2011. About Cryo-Cell International, Inc. Based in Oldsmar, Florida, with over 230,000 clients worldwide, Cryo-Cell is one of the largest and most established family cord blood banks. ISO 9001:2008 certified and accredited by the AABB, Cryo-Cell operates in a state-of-the- Forward-Looking Statement Statements wherein the terms “believes” Additional Information and Where To Find It The Company will be filing documents with the SEC, including the filing by the Company of a proxy statement in connection with the 2011 annual meeting of stockholders. Stockholders are urged to read the Company`s proxy statement for the 2011 annual meeting of stockholders when it becomes available, as well as other relevant documents filed by the Company with the SEC, because they will contain important information. The Company`s definitive proxy statement will be mailed to stockholders of the Company. Stockholders may obtain free copies of these documents (when they are available) and other documents filed with the SEC at the Company’s website (http://www.cryo- Information Regarding Participants Information regarding the officers and directors of the Company is included in the Company’s Annual Report on Form 10-K filed with the SEC on February 28, 2011. More detailed information regarding the identity of potential participants, and their direct or indirect interests, by securities, holdings or otherwise, will be set forth in the proxy statement and other materials to be filed by the Company with SEC in connection with the 2011 annual meeting of stockholders. Contact: Julia Avery (Investors) Stern Investor Relations, Inc. 212-362-1200 julia@sternir.com Irene Smith (Media) Cryo-Cell International, Inc. 813-749-2100 ismith@cryo- # # # Cryo-Cell is one of the largest &most established family cord blood banks. ISO 9001:2000 certified and accredited by the AABB, Cryo-Cell operates in a state-of-the- End
Account Email Address Disclaimer Report Abuse Page Updated Last on: May 26, 2011
|
|